|Articles|January 17, 2018
ANVISA Adopts Certara’s Phoenix Software for Drug Regulatory Reviews
Advertisement
Certara announced that the Brazilian National Health Surveillance Agency, ANVISA is now also employing Certara’s Phoenix WinNonlin software for reviewing drug regulatory submissions. With the adoption of Certara's software, reviewed studies will be evauated to see if they follow good bioequivalence practices.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
5